Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Salmedix, Inc. (now Teva Pharmaceuticals)

Based in San Diego, CA, USA, Salmedix, Inc. was dedicated to creating value for patients and oncologists by developing unappreciated cancer drugs, with an initial commercial focus on hematologic cancers. In June 2005, Cephalon, Inc. (Nasdaq: CEPH) completed its acquisition of Salmedix, Inc.

Search Projects

  • Chief Operating Officer
  • Executive Vice President, Research and Development
  • Vice President, Clinical development
  • Senior Director, Clinical Research